Transformation or Progression from Adenocarcinoma to Small Cell Lung Cancer Detected by Serially Tracking Mutations in the Blood

<b>Background</b>: Circulating tumour DNA (ctDNA) has emerged as a promising biomarker for monitoring non-small-cell lung cancer (NSCLC). This has enabled the monitoring of clinically actionable mutations over the course of therapy. <b>Case presentation:</b> We present the case of a 74-year-old fema...

Descripción completa

Detalles Bibliográficos

Autores principales:	Arutha Kulasinghe, James Monkman, Mark Nalder, Connor O’Leary, Rahul Ladwa, Ken O’Byrne
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2020-11-01
Colección:	Reports
Materias:	circulating tumour dna non-small-cell lung cancer mutations
Acceso en línea:	https://www.mdpi.com/2571-841X/3/4/33
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!